Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

[11] Spranger S(2019)FDA approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors Clin cancer research: official J Am Association Cancer Res 25 3753-56

[12] Luke JJ(2021)High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types Annals of oncology: official journal of the European Society for Medical Oncology 32 661-86

[13] Bao R(2017)Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy Cell 168 707-6

[14] Zha Y(2019)Harnessing innate immunity in cancer therapy Nature 574 45-14

[15] Hernandez KM(2021)Turning cold tumors into hot tumors by improving T-cell infiltration Theranostics 11 5365-83

[16] Li Y(2016)Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells Oncol Lett 12 631-200

[17] Jackson CM(2005)Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 65 5009-44

[18] Choi J(2021)Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7 Stem Cell Res Ther 12 349-22

[19] Lim M(2013)Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis BJU Int 111 977-30

[20] Qi Y(2005)Imiquimod: in superficial basal cell carcinoma Am J Clin Dermatol 6 195-93e7

[11] Spranger S(2019)FDA approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors Clin cancer research: official J Am Association Cancer Res 25 3753-56

[12] Luke JJ(2021)High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types Annals of oncology: official journal of the European Society for Medical Oncology 32 661-86

[13] Bao R(2017)Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy Cell 168 707-6

[14] Zha Y(2019)Harnessing innate immunity in cancer therapy Nature 574 45-14

[15] Hernandez KM(2021)Turning cold tumors into hot tumors by improving T-cell infiltration Theranostics 11 5365-83

[16] Li Y(2016)Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells Oncol Lett 12 631-200

[17] Jackson CM(2005)Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 65 5009-44

[18] Choi J(2021)Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7 Stem Cell Res Ther 12 349-22

[19] Lim M(2013)Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis BJU Int 111 977-30

[20] Qi Y(2005)Imiquimod: in superficial basal cell carcinoma Am J Clin Dermatol 6 195-93e7